Mizuho Securities USA’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18M | Sell |
150,049
-30,676
| -17% | -$3.54M | 0.43% | 37 |
|
|
2025
Q4 | $18.9M | Sell |
180,725
-1,197
| -0.7% | -$112K | 0.31% | 42 |
|
|
2025
Q3 | $15.3M | Buy |
181,922
+8,379
| +5% | +$690K | 0.31% | 50 |
|
|
2025
Q2 | $13.7M | Sell |
173,543
-29,004
| -14% | -$2.31M | 0.29% | 56 |
|
|
2025
Q1 | $18.2M | Sell |
202,547
-37,205
| -16% | -$3.47M | 0.39% | 40 |
|
|
2024
Q4 | $23.9M | Buy |
239,752
+75,383
| +46% | +$7.77M | 0.43% | 30 |
|
|
2024
Q3 | $18.7M | Sell |
164,369
-30,916
| -16% | -$3.67M | 0.4% | 27 |
|
|
2024
Q2 | $24.2M | Buy |
+195,285
| New | +$25.2M | 0.53% | 27 |
|
|
2022
Q3 | – | Sell |
-3,584
| Closed | -$327K | – | 249 |
|
|
2022
Q2 | $327K | Hold |
3,584
| – | – | 0.05% | 116 |
|
|
2022
Q1 | $294K | Sell |
3,584
-8,778
| -71% | -$692K | 0.04% | 165 |
|
|
2021
Q4 | $947K | Sell |
12,362
-1,152
| -9% | -$91.8K | 0.09% | 146 |
|
|
2021
Q3 | $1.01M | Buy |
13,514
+327
| +2% | +$24.9K | 0.1% | 152 |
|
|
2021
Q2 | $1.03M | Sell |
13,187
-11,804
| -47% | -$878K | 0.08% | 149 |
|
|
2021
Q1 | $1.84M | Buy |
+24,991
| New | +$1.84M | 0.18% | 104 |
|
|
2020
Q3 | – | Sell |
-5,327
| Closed | -$393K | – | 183 |
|
|
2020
Q2 | $393K | Sell |
5,327
-218,002
| -98% | -$16.4M | 0.03% | 114 |
|
|
2020
Q1 | $16.4M | Buy |
223,329
+217,806
| +3,944% | +$17.1M | 2.43% | 5 |
|
|
2019
Q4 | $479K | Sell |
5,523
-224,513
| -98% | -$18.4M | 0.02% | 132 |
|
|
2019
Q3 | $18.5M | Buy |
+230,036
| New | +$18.4M | 1.1% | 5 |
|
|
2018
Q2 | – | Sell |
-175,545
| Closed | -$9.12M | – | 214 |
|
|
2018
Q1 | $9.12M | Buy |
175,545
+156,151
| +805% | +$8.43M | 0.57% | 17 |
|
|
2017
Q4 | $1.04M | Buy |
19,394
+3,352
| +21% | +$186K | 0.06% | 97 |
|
|
2017
Q3 | $980K | Buy |
+16,042
| New | +$973K | 0.05% | 113 |
|
|
2017
Q1 | – | Sell |
-9,892
| Closed | -$556K | – | 216 |
|
|
2016
Q4 | $556K | Sell |
9,892
-22,401
| -69% | -$1.31M | 0.02% | 160 |
|
|
2016
Q3 | $1.92M | Buy |
32,293
+26,021
| +415% | +$1.52M | 0.16% | 91 |
|
|
2016
Q2 | $345K | Buy |
+6,272
| New | +$334K | 0.05% | 139 |
|
|
2016
Q1 | – | Sell |
-52,400
| Closed | -$2.64M | – | 145 |
|
|
2015
Q4 | $2.64M | Buy |
+52,400
| New | +$2.64M | 0.33% | 37 |
|
|
2015
Q3 | – | Sell |
-13,999
| Closed | -$760K | – | 168 |
|
|
2015
Q2 | $760K | Sell |
13,999
-77,638
| -85% | -$4.35M | 0.09% | 101 |
|
|
2015
Q1 | $5.03M | Sell |
91,637
-28,852
| -24% | -$1.63M | 0.65% | 38 |
|
|
2014
Q4 | $6.53M | Sell |
120,489
-61,856
| -34% | -$3.45M | 0.64% | 37 |
|
|
2014
Q3 | $10.3M | Buy |
+182,345
| New | +$10.2M | 1.21% | 24 |
|
|
2014
Q1 | – | Sell |
-118,862
| Closed | -$5.68M | – | 76 |
|
|
2013
Q4 | $5.68M | Sell |
118,862
-41,007
| -26% | -$1.87M | 0.47% | 49 |
|
|
2013
Q3 | $7.26M | Buy |
159,869
+6,241
| +4% | +$285K | 0.46% | 37 |
|
|
2013
Q2 | $6.81M | Buy |
+153,628
| New | +$6.86M | 0.34% | 37 |
|
Other funds holding MRK
VCM
VPM
Mizuho Securities USA's MRK Position: Q1 2026 in Review
Mizuho Securities USA reduced its Merck (MRK) stake by 17% in Q1 2026, selling an estimated $3.54M and leaving 150,049 shares worth $18M. The position accounts for 0.43% of the portfolio, ranked #37.
Mizuho Securities USA first reported a position in MRK in Q2 2013 and has held it in 32 quarters since. The position peaked at $24.2M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Mizuho Securities USA held 150,049 shares of Merck worth $18M as of Q1 2026.
- Mizuho Securities USA sold 30,676 Merck shares in Q1 2026, an estimated $3.54M.
- Merck made up 0.43% of Mizuho Securities USA's portfolio in Q1 2026, its #37 holding.
- Mizuho Securities USA first reported a position in Merck in Q2 2013 and has held it in 32 quarters since.
- Mizuho Securities USA's Merck position peaked at $24.2M in Q2 2024.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.